We thank Dr Maass et al.1 for their interest in our study2 and are pleased to provide a reply to their questions.
The authors express their concern about the long-term performance of the subcutaneous implantable cardioverter-defibrillator (S-ICD), considering the increase in shock impedance in the years after implantation. According to Ohm’s law, a higher shock impedance results in a lower shock success rate. However, despite the significant increase in shock impedance in our analysis, we showed a first shock success during defibrillation testing (DFT) of 91.4% during the replacement procedure. This is similar to the DFT success rate in de novo S-ICD implants and in transvenous devices.3,4 Four of the patients with a high PRAETORIAN score underwent a DFT after pocket revision during the replacement procedure. These patients were among those with the largest increase in shock impedance (103Ω ± 37Ω during implant vs. 145Ω ± 47Ω during replacement). DFT was successful after one 65 J shock in three of these patients (75%), whereas the fourth patient had a successful DFT at 80 J, similar to his implant procedure. These results suggest that impedance is not as predictive of defibrillation success as anticipated.
Shock impedance represents the resistance between the coil and the generator of the S-ICD and depends mostly on generator-lead distance and the body tissues between these electrodes. As Dr Maass et al. described, excess formation of fibrotic tissue around the lead or generator or weight gain can result in an increase in shock impedance. Shock impedances >100Ω are associated with a higher chance of DFT failure, but a positive predictive value of 23% indicates this variable is unsuited as a predictor for shock success.5 Moreover, a low shock impedance does not necessarily correspond with a successful DFT. When the generator is too anteriorly positioned, the electrical current may shunt over the thoracic wall, resulting in a conversion failure with a low shock impedance. Alternatively, the non-invasive PRAETORIAN score evaluates the implant position of the S-ICD and takes generator-lead distance and adipose tissue into account. A retrospective validation of the PRAETORIAN score demonstrated that half of all patients with a high PRAETORIAN score failed their DFT.5 In our study, we showed a high defibrillation success and a low overall PRAETORIAN score, despite increases in impedance. Moreover, a recent analysis of 566 patients showed that patients with a high PRAETORIAN score have a 19-fold higher risk on ineffective shocks during follow-up (hazard ratio = 19.03; confidence interval 4.75–76.20; P = 0.003).6 This seems to confirm our suggestion that the PRAETORIAN score is a better predictor for shock success than impedance.
As mentioned by Dr Maass et al., a successful shock on an induced arrhythmia during the implant or replacement procedure does not guarantee shock success during a spontaneous ventricular arrhythmia. The ongoing PRAETORIAN DFT trial, of which the results are expected in 2024, will prospectively validate the PRAETORIAN score and compare the predictive values of the PRAETORIAN Score and DFT for shock success in spontaneous arrhythmias.7
Conflict of interest: none declared.
Contributor Information
Willeke van der Stuijt, Department of Clinical and Experimental Cardiology, Amsterdam UMC, Location AMC, Room C0-333, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Lonneke Smeding, Department of Clinical and Experimental Cardiology, Amsterdam UMC, Location AMC, Room C0-333, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Reinoud E Knops, Department of Clinical and Experimental Cardiology, Amsterdam UMC, Location AMC, Room C0-333, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
References
- 1. Maass AH, Groenveld HF, Mulder BA, Blaauw Y, Rienstra M. High shock impedance during subcutaneous implantable defibrillator generator replacements. Europace 2022;24:349--50. [DOI] [PubMed] [Google Scholar]
- 2. Van Der Stuijt W, , QuastE, , BaalmanSWE, , De WildeKC, , BrouwerTF, , Wilde AAM et al. . Complications related to elective generator replacement of the subcutaneous implantable defibrillator. Europace 2021;23:395–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P et al. ; EFFORTLESS Investigator Group. Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol 2017;70:830–41. [DOI] [PubMed] [Google Scholar]
- 4. Healey JS, Hohnloser SH, Glikson M, Neuzner J, Mabo P, Vinolas X et al. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE). Lancet 2015;385: 785–91. [DOI] [PubMed] [Google Scholar]
- 5. Quast A-FBE, Baalman SWE, Brouwer TF, Smeding L, Wilde AAM, Burke MC et al. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: the PRAETORIAN score. Heart Rhythm 2019;16:403–10. [DOI] [PubMed] [Google Scholar]
- 6. Forleo GB, Gasperetti A, Breitenstein A, Laredo M, Schiavone M, Ziacchi M et al. Subcutaneous implantable cardioverter defibrillator and defibrillation testing: a propensity-matched pilot study. Heart Rhythm 2021; doi:10.1016/j.hrthm.2021.06.1201. [DOI] [PubMed] [Google Scholar]
- 7. Quast A-FBE, Baalman SWE, Betts TR, Boersma LVA, Bonnemeier H, Boveda S et al. Rationale and design of the PRAETORIAN-DFT trial: a prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing. Am Heart J 2019;214:167–74. [DOI] [PubMed] [Google Scholar]